Wondering if Tandem Diabetes Care at around $21 a share is a hidden bargain or a value trap? You are not alone, and that is exactly what we are going to unpack here. The stock has bounced 2.2% over ...

Few things are more frustrating than topping a fairway wood—in other words, thinking you're going to blast one, and it ends ...

If you are wondering whether Arcutis Biotherapeutics is still worth a closer look after its big run up, or if most of the upside is already priced in, this article is for you. The stock has been ...

Rec Room is kind of like a virtual playground where you can just hang out and do a bunch of different stuff. It’s totally ...